Nigel Hussain

发表

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2: Conversion of the Key Intermediate SB-235349 to SB-214857-A

Gary Francis GlaxoSmithKline Breen, A. Wells, J. S. Carey, 2003 .